戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ns, and may drive the autoimmune response in systemic autoimmune disease.
2 and elements necessary for the initiation of systemic autoimmune disease.
3 es may develop, and perhaps be prevented, in systemic autoimmune disease.
4 ht to trigger the pathogenic consequences of systemic autoimmune disease.
5  specificities in sera from 58 patients with systemic autoimmune disease.
6     The MHC exerts an important influence on systemic autoimmune disease.
7 llogeneic CAR-T cells in three patients with systemic autoimmune disease.
8       Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease.
9 rs and patients with rheumatoid arthritis, a systemic autoimmune disease.
10 s that affect the priming and progression of systemic autoimmune disease.
11  and function and that H2S deficiency led to systemic autoimmune disease.
12 entral to the pathogenesis of this prototype systemic autoimmune disease.
13 on inhibits inflammatory pathology caused by systemic autoimmune disease.
14  lupus erythematosus (SLE) is the prototypic systemic autoimmune disease.
15 arthritis as well as other manifestations of systemic autoimmune disease.
16 CD4+ T cells in both spontaneous and induced systemic autoimmune disease.
17                    Rheumatoid arthritis is a systemic autoimmune disease.
18 o the contribution of Toll-like receptors in systemic autoimmune disease.
19  within the kappa locus may be shared with a systemic autoimmune disease.
20 athway may be related to the pathogenesis of systemic autoimmune disease.
21 our in the search for effective treatment of systemic autoimmune diseases.
22 oantibodies), resulting in organ-specific or systemic autoimmune diseases.
23 ntigen targeted by autoantibodies in several systemic autoimmune diseases.
24 ich is the cellular signature of a subset of systemic autoimmune diseases.
25 sis include nuclear autoantigens targeted in systemic autoimmune diseases.
26  the feature of autoantibody production with systemic autoimmune diseases.
27 e transformed the treatment options for many systemic autoimmune diseases.
28 ne responses and might also be pathogenic in systemic autoimmune diseases.
29  and the putative pathogenic role of LDGs in systemic autoimmune diseases.
30  been linked with autoimmune retinopathy and systemic autoimmune diseases.
31 the treatment of multiple organ fibrosis and systemic autoimmune diseases.
32 city in relation to disease heterogeneity in systemic autoimmune diseases.
33 rols effector T cell function in people with systemic autoimmune diseases.
34 mic lupus erythematosus (SLE) and many other systemic autoimmune diseases.
35 mmune responses to viral pathogens and other systemic autoimmune diseases.
36 epresent a large fraction of autoantigens in systemic autoimmune diseases.
37 mains, with PCS scores in the range of other systemic autoimmune diseases.
38 nts useful in rheumatoid arthritis and other systemic autoimmune diseases.
39 ipheral B-cell development in the context of systemic autoimmune diseases.
40 ies the production of many autoantibodies in systemic autoimmune diseases.
41 likely play a key role in the development of systemic autoimmune diseases.
42 ed not only organ-specific diseases but also systemic autoimmune diseases.
43 arding occupational exposures that may cause systemic autoimmune diseases.
44 he treatment of multiple sclerosis and other systemic autoimmune diseases.
45 rol sera and with sera from 21 patients with systemic autoimmune diseases.
46 n why intracellular antigens are targeted in systemic autoimmune diseases.
47 l remission from organ-specific-, as well as systemic, autoimmune diseases.
48  7 (TLR7) signalling as a mechanism of human systemic autoimmune disease(1-7), evidence of lupus-caus
49    Sera from 639 subjects (417 patients with systemic autoimmune disease, 13 with sarcoidosis, 44 wit
50 Rheumatoid arthritis (RA) is the most common systemic autoimmune disease, affecting approximately 1%
51                             The induction of systemic autoimmune disease after virus infection in Sig
52                One patient had a preexistent systemic autoimmune disease and another's was later diag
53 alpha deficient mice (IL-2Ralpha-KO) develop systemic autoimmune disease and die from severe anemia b
54 daptive immune systems in the development of systemic autoimmune disease and explain the preponderanc
55 paired Treg suppressive function, leading to systemic autoimmune disease and strong anti-tumor immuni
56 terial disease in allograft vasculopathy and systemic autoimmune diseases and involve pathogenic Abs
57                       Evidence suggests that systemic autoimmune diseases and primary immunodeficienc
58 ssociations have also been reported in other systemic autoimmune diseases and suggest that there are
59 ations between occupation and death from any systemic autoimmune disease, and from RA, SLE, and syste
60 ut rapidly developed severe lymphadenopathy, systemic autoimmune disease, and thrombocytopenia.
61  beta T cell-dependent mechanisms can induce systemic autoimmune disease, and to address the roles of
62 (5 for hematologic malignant diseases, 4 for systemic autoimmune diseases, and 2 following organ tran
63 phatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has
64                                              Systemic autoimmune diseases are a genetically complex,
65                                              Systemic autoimmune diseases are characteristically asso
66                                              Systemic autoimmune diseases are characterized by specif
67                                              Systemic autoimmune diseases are characterized by the fa
68 tigens targeted across the spectrum of human systemic autoimmune diseases are efficiently cleaved by
69 d concomitant thrombosis risk factors and/or systemic autoimmune disease at the time of thrombosis.
70 stem, and mice lacking TAM receptors develop systemic autoimmune diseases because of inefficient nega
71 autoantigens targeted across the spectrum of systemic autoimmune diseases (but not nonautoantigens) a
72 ated the requirements for the development of systemic autoimmune disease by using bone marrow chimera
73                                     Although systemic autoimmune diseases can be accompanied by multi
74 rome has become the prototype for an aseptic systemic autoimmune disease caused by a known environmen
75     Rheumatoid arthritis (RA) is a prevalent systemic autoimmune disease, caused by a combination of
76      Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of t
77 n development of Sjogren's syndrome (SjS), a systemic autoimmune disease characterized by a progressi
78 temic lupus erythematosus (SLE) is a complex systemic autoimmune disease characterized by a wide rang
79      Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by antinuclear
80 mic lupus erythematosus (SLE) is a prototype systemic autoimmune disease characterized by flares of h
81 s(lpr)) mice develop a rapidly fatal form of systemic autoimmune disease characterized by glomerulone
82                Primary Sjogren syndrome is a systemic autoimmune disease characterized by mouth and e
83           Systemic sclerosis (SSc) is a rare systemic autoimmune disease characterized by skin and or
84  lupus erythematosus (SLE) is a prototypical systemic autoimmune disease characterized by the product
85 temic lupus erythematosus (SLE) is a chronic systemic autoimmune disease characterized by the product
86      Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, characterized by loss of to
87                           We also review the systemic autoimmune diseases classically associated with
88                                              Systemic autoimmune diseases comprise a complex, heterog
89 tomyositis, and inclusion body myositis) are systemic autoimmune diseases defined by chronic muscle w
90    Patients with juvenile dermatomyositis, a systemic autoimmune disease, displayed a profound skewin
91                     Elucidating how a single systemic autoimmune disease engages distinct immune effe
92 me sequencing of two unrelated kindreds with systemic autoimmune disease featuring antinuclear antibo
93 sease occurring in association with a second systemic autoimmune disease for which classification cri
94  B has been implicated in the development of systemic autoimmune disease; however, there has been no
95 s erythematosus is considered a prototype of systemic autoimmune diseases; however, despite considera
96 PK (HR = 4.28, 95% CI 2.38-7.71), history of systemic autoimmune disease (HR = 2.83, 95% CI 1.63-4.90
97                                              Systemic autoimmune disease in humans and mice is charac
98  autoantibodies, especially anti-dsDNA, from systemic autoimmune disease in MRL, NZB/W, and motheaten
99 ce of regulatory T cells (Tregs) and a fatal systemic autoimmune disease in scurfy mice.
100 ptor or its ligand (FasL) lead to lupus-like systemic autoimmune diseases in mice and in some humans.
101                                 Unlike other systemic autoimmune diseases, in AS, the innate immune s
102 y arthritis, as assessed histologically, and systemic autoimmune disease, including glomerulonephriti
103 upations were associated with death from any systemic autoimmune disease, including mining machine op
104 f occupations was associated with death from systemic autoimmune diseases, including several of a pri
105 Ab-dependent and Ab-independent functions in systemic autoimmune diseases, including systemic lupus e
106                                  Independent systemic autoimmune disease is an uncommon feature.
107      The findings reveal that injury-induced systemic autoimmune disease is exacerbated in the absenc
108                                              Systemic autoimmune disease is frequently characterized
109   The possible role of B7.2 dysregulation in systemic autoimmune diseases is discussed.
110 ic lupus erythematosus (SLE), the prototypic systemic autoimmune disease, is a debilitating multisyst
111 nts is considered to be the primary cause of systemic autoimmune diseases, like systemic lupus erythe
112  cells maturing to produce autoantibodies in systemic autoimmune diseases, like those in normal immun
113  versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis).
114     Systemic sclerosis, or scleroderma, is a systemic autoimmune disease manifest by vascular damage
115                                              Systemic autoimmune disease manifestations, including ly
116 ment of corneal ulceration in the setting of systemic autoimmune disease may represent progression of
117          Our results suggest that death from systemic autoimmune diseases may be associated with occu
118  both foreign Ag-driven immune responses and systemic autoimmune diseases mediated by B lymphocytes.
119 pothesis that induction of autoantibodies in systemic autoimmune diseases might be triggered by a T c
120 ontrast to oligoclonal expansion observed in systemic autoimmune disease models, insulin-binding B ce
121 1), systemic sclerosis (n = 5,642), or other systemic autoimmune disease (n = 4,270).
122 s (SSc), or scleroderma, is a rare, complex, systemic autoimmune disease of unknown aetiology, charac
123 ccupation was associated with death from any systemic autoimmune disease (OR 1.3 [95% CI 1.2-1.4]), a
124 is (SSc) remains a challenging and enigmatic systemic autoimmune disease, owing to its complex pathog
125 , but in no sera from 94 patients with other systemic autoimmune diseases (P = 0.016).
126  of morbidity and mortality in patients with systemic autoimmune diseases, particularly systemic lupu
127                                   Studies of systemic autoimmune diseases point to characteristic mic
128 blic, such as teachers, were associated with systemic autoimmune disease-related death, whereas other
129 epitopes recognized by pathogenic T cells in systemic autoimmune disease remain poorly defined.
130 ty in vivo; the mice rapidly developed fatal systemic autoimmune disease resembling the FoxP3 KO phen
131                                              Systemic autoimmune diseases result from interactions be
132 oplasmic autoantibody (ANCA) vasculitis is a systemic autoimmune disease resulting in small-vessel in
133  (the most common form), associated to other systemic autoimmune diseases (SAD-APS), and catastrophic
134                                           In systemic autoimmune disease, self-tolerance fails, leadi
135                                Patients with systemic autoimmune diseases show increased incidence of
136 osaccharide chains (N-glycans), results in a systemic autoimmune disease similar to human systemic lu
137 king Btk an attractive therapeutic target in systemic autoimmune disease such as SLE.
138 H are caused by capillaritis associated with systemic autoimmune diseases such as antineutrophil cyto
139                                              Systemic autoimmune diseases such as lupus affect multip
140                                           In systemic autoimmune diseases such as lupus the immune sy
141 e complexes in the serum are associated with systemic autoimmune diseases such as lupus.
142  adaptive immunity that is characteristic of systemic autoimmune diseases such as systemic lupus eryt
143 uced by IFNs during viral. infections and in systemic autoimmune diseases such as systemic lupus eryt
144 ay be of benefit in the treatment of chronic systemic autoimmune diseases such as systemic lupus eryt
145 s strongly implicated in the pathogenesis of systemic autoimmune diseases, such as lupus, and rare mo
146 y self-NA also underlies the pathogenesis of systemic autoimmune diseases, such as systemic lupus ery
147 nd their contribution to the pathogenesis of systemic autoimmune diseases suggest new opportunities f
148  Autoimmunity to DNA in mouse models for the systemic autoimmune disease systemic lupus erythematosus
149                            In the prototypic systemic autoimmune disease systemic lupus erythematosus
150 G production, as well as in the serum of the systemic autoimmune disease systemic lupus erythematosus
151                         Type 1 diabetes is a systemic autoimmune disease that can be cured by transpl
152 temic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that disproportionately affe
153                        Lupus is a prototypic systemic autoimmune disease that has a significant genet
154      Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is accompanied by the e
155  erythematosus (SLE) is a heterogenous multi-systemic autoimmune disease that is associated with cons
156         Primary Sjogren's syndrome (SS) is a systemic autoimmune disease that is characterized by ker
157                   Lupus-prone mice develop a systemic autoimmune disease that is dependent upon the B
158 ot MHC class I, permitted the development of systemic autoimmune disease that is indistinguishable fr
159              Dermatomyositis (DM) is a rare, systemic autoimmune disease that most frequently affects
160               Rheumatoid arthritis (RA) is a systemic autoimmune disease that predominantly affects t
161      Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that predominantly affects w
162 mic lupus erythematosus (SLE) is a prototype systemic autoimmune disease that results from a break in
163 d autoimmunity (mHgIA) is a T cell-dependent systemic autoimmune disease that shares a number of comm
164  in healthy individuals and in patients with systemic autoimmune diseases that affect the kidney will
165 opathies (IIMs) are a heterogeneous group of systemic autoimmune diseases that affect the skeletal mu
166 ic inflammatory myopathies (IIMs), which are systemic autoimmune diseases that are characterized by m
167 r, many chemokines have been associated with systemic autoimmune diseases that have chronic IFN signa
168                                  As for many systemic autoimmune diseases, the most important future
169 Tim-1(Deltamucin) mice did not develop frank systemic autoimmune disease unless they were crossed ont
170 , including infectious, most commonly viral, systemic autoimmune diseases, vaccine-associated process
171                                              Systemic autoimmune disease was more common in nerve lar
172  negative screening for vasculitis and other systemic autoimmune disease were included.
173 antiphospholipid syndrome (PAPS), a nonlupus systemic autoimmune disease, were hyporesponsive to P2X7
174 s to DNA and nucleoproteins are expressed in systemic autoimmune diseases, whereas B cells producing
175 stemic lupus erythematosus (SLE) is a common systemic autoimmune disease with complex etiology but st
176                      Gluten sensitivity is a systemic autoimmune disease with diverse manifestations.
177              These results suggest that in a systemic autoimmune disease with multiple manifestations
178        Sjogren's disease (SjD) is a chronic, systemic autoimmune disease with no approved disease-mod
179             Systemic sclerosis is an orphan, systemic autoimmune disease with no FDA-approved treatme
180  Mixed connective tissue disease (MCTD) is a systemic autoimmune disease with significant morbidity a
181 i-dsDNA Id(+) B cells in mice suffering from systemic autoimmune disease with SLE-like features.
182 rtk (TAM) triply knockout (TKO) mice exhibit systemic autoimmune diseases, with characteristics of in

 
Page Top